• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Changing a Facial Serum Formula After Saudi GHAD Listing: What Should Importers Recheck?

A facial serum that has already been notified in Saudi Arabia is not a "fixed" product. The moment the formula, the fragrance, a supplier, the packaging, or the wording on the carton changes, the…

Category: Skincare Sourcing Guides • Author: laeyo • Published: 2026-11-07 • Views: 41

A facial serum that has already been notified in Saudi Arabia is not a “fixed” product. The moment the formula, the fragrance, a supplier, the packaging, or the wording on the carton changes, the product described in your notification record and your safety file may no longer match what is actually being manufactured. For importers and brand owners, that gap is where shipments get held, labels get rejected, and claims get challenged after launch. This guide walks through what to recheck after a reformulation, who owns each item, and what evidence to request from the manufacturer before the new batch ships.

Informational only, not legal advice. Confirm Saudi-specific requirements with your local notifier and, where needed, a qualified regulatory consultant.

Why a formula change is a regulatory event, not a production tweak

In the Saudi framework, cosmetics sit under SFDA oversight together with the Gulf (GSO) cosmetic standards, and the local importer or notifier carries the legal responsibility for the product on the market. The notification is filed through SFDA’s electronic system, and SFDA publishes a list of notified products that buyers, retailers, and customs can check. That visibility cuts both ways: a notified product is easy to verify, and a mismatch between the notified description and the shipped product is equally easy to spot.

Manufacturers can generate data, run tests, and prepare documents. Only the local responsible entity can update the notification and hold the market-facing record. That division of labor should be written into the project plan from day one, because a reformulation that is technically finished but not reflected in the file is not a finished reformulation.

Step 1: Classify the change before you open the file

Not every change deserves a full re-test. Over-testing burns three to six weeks and a meaningful budget; under-testing creates a compliance exposure that surfaces at customs or in a consumer complaint. Classify first, then decide scope in writing.

Change type Typical risk level Primary recheck focus
Fragrance supplier or fragrance formula change High Allergen declaration, IFRA documentation, safety assessment, warnings, preservative interaction
Active ingredient swap or dosage change High Claim substantiation, tolerance/safety assessment, stability, label
Preservative system change High Challenge test, pH, packaging compatibility, safety file
Water/solvent ratio or pH adjustment Medium–High Microbiological robustness, stability, packaging interaction
Supplier change, same INCI and grade Medium COA comparison, impurity profile, stability spot check
Texture modifier, thickener, or sensory upgrade Medium Stability, pump/dropper compatibility, consumer perception
Packaging change, formula unchanged Medium Compatibility, closure torque, seal integrity, label adhesion
Label or claim wording change only Varies Claims boundary, Arabic label approval, advertising compliance

A fragrance change is the clearest example of a high-risk change that looks low-risk on a purchase order. A new fragrance house can mean a different allergen profile, different impurities, and a different interaction with the preservative system. Even when the fragrance level stays at 0.3%, the exposure assessment, the ingredient risk review, the tolerance question, and the warning statements all have to be revisited — and the safety file has to say so.

Step 2: The importer’s recheck list

Notification record and responsible entity

  • Confirm the notified product description still matches: product name, variant, function, packaging format.
  • Confirm who is the current notifier of record and that they are willing to amend or re-file.
  • Confirm whether the reformulated version needs a new notification or an update to the existing one — this is a notifier decision, not a factory decision.
  • Check that the product still appears correctly on SFDA’s published list after any update.

Safety file and product information

  • Reissue or amend the safety assessment for the new formula — a new fragrance or active means a new ingredient review, not a re-dated cover page.
  • Update the ingredient risk review with new supplier, new INCI where applicable, and new impurity information.
  • Revisit the tolerance/safety conclusion for leave-on facial products, especially for sensitive-skin or “derm-friendly” positioning.
  • Confirm whether the product safety report used for other markets (EU CPSR, China filing, US safety substantiation) is also updated, so the file set stays consistent across regions.

Arabic labeling and allergen declaration

  • Confirm Arabic labeling is present and consistent with the new formula — ingredient list order changes with any concentration change.
  • Confirm declarable fragrance allergens are reflected in both the ingredient list and the safety assessment, based on the list your notifier requires.
  • Confirm warnings and cautions are re-reviewed, not copy-pasted from the previous version.
  • Confirm batch code, production date, expiry/PAO, and country-of-origin statements remain correct for the new batch.
  • Confirm the final Arabic/English artwork is approved by the importer before printing, not after cartons arrive.

Claims boundary

  • Re-read every claim against the new formula — a claim supported by the old active may be unsupported now.
  • Keep the product in cosmetic territory. Medical or therapeutic claims can change the classification of the product, and that risk runs through the label, the Amazon/retail listing, and the advertising copy alike.
  • Align claims to the evidence you actually hold: consumer perception data, instrumental measurements, or both.

Microbiology, stability, and packaging

  • Assess whether pH, water activity, or nutrient load changed enough to justify a preservative challenge re-test. A fragrance change should trigger this assessment, even if the conclusion is “no re-test required.”
  • Confirm accelerated and real-time stability cover the new formula, including high-temperature conditions relevant to Gulf supply chains.
  • Confirm compatibility between the new formula and the chosen container and closure: viscosity versus pump or dropper, leakage, gasket swelling, label adhesion, and fragrance-plastic interaction.
  • Confirm seal integrity and transit testing for the finished pack.

Post-market surveillance

  • Set an adverse event monitoring window for the first batches of the reformulated product, and compare trends against the previous version.
  • Keep a complaint log that can be produced on request if the authority asks.

Step 3: The document pack to request from your manufacturer

Ask for these as a single pack, referenced to a specific formula version. A manufacturer that manages version control well will answer quickly; one that does not will send mismatched documents, which is itself a finding.

  • Formula record with a unique formula ID, the reason for the change, old and new INCI, supplier, and batch references.
  • Impact assessment covering sensory, stability, efficacy, preservative, regulatory, packaging, and cost.
  • Test scope decision: which tests were repeated, which were waived, and on what risk basis.
  • COA and SDS for the new raw materials, plus the finished product specification.
  • Stability data for the new formula, including high-temperature and cycle conditions.
  • Microbiological data, or a documented challenge-test waiver rationale.
  • Fragrance documentation: IFRA certificate and allergen declaration for the new fragrance.
  • Packaging compatibility report for the actual container and closure used.
  • GMP or production qualification evidence for the manufacturing site.
  • Approval record showing R&D, regulatory, quality, and project sign-off at the right level for the change.

Step 4: Plan the timeline around dependencies, not hope

  • Week 1: change classification, notifier consultation, decision on update versus new notification.
  • Weeks 1–3: stability and micro assessment; packaging compatibility if the pack also changes.
  • Weeks 2–4: safety file amendment and label/allergen rework; artwork review in parallel, not after.
  • Weeks 3–5: pilot or first production batch, with batch records and COA generated.
  • Weeks 4–6: final documentation handoff and notification update before commercial shipment.

Compress the artwork and pilot stages only if the change is a pure supplier substitution with an identical INCI and a clean COA comparison. Never compress the safety file or the notification update to hit a launch date — that is the one delay that does not recover.

Red lines: what not to cut

  • Do not ship a reformulated serum against an unchanged notification record.
  • Do not replace the safety assessment with a re-dated version of the old one.
  • Do not skip the fragrance allergen review because “the fragrance level is low.”
  • Do not skip the preservative challenge assessment after a fragrance or pH change.
  • Do not print Arabic artwork without written importer approval.
  • Do not keep therapeutic or medical-style claims on a cosmetic product.

Common ways reformulations fail after listing

1. The label says one thing, the file says another

Symptom: customs or the retailer flags an ingredient mismatch.
Root cause: ingredient list order printed from an older formula version.
Prevention: tie artwork version to formula ID.
Request from factory: signed formula-to-label cross-check for the specific batch.

2. The fragrance changed and nobody reopened the safety file

Symptom: the safety report references a fragrance that is no longer used.
Root cause: change treated as a purchasing decision only.
Prevention: treat fragrance supplier change as a high-risk change with a mandatory safety review.
Request from factory: IFRA certificate, allergen declaration, and updated ingredient risk review.

3. Packaging compatibility failure

Symptom: dropper delivers an inconsistent dose, the pump clogs, the bottle weeps at the shoulder, or the label lifts in humid retail conditions.
Root cause: viscosity or solvent balance shifted with the new formula; compatibility was never re-tested against the actual pack.
Prevention: re-run compatibility and seal integrity whenever the formula or the pack changes.
Request from factory: compatibility report covering the exact bottle, dropper, and closure, plus transit and leak test results.

4. Documentation failure

Symptom: COA, SDS, stability, and micro reports arrive with different formula IDs, different dates, or a missing page.
Root cause: no single document owner and no version control across departments.
Prevention: request one consolidated pack per formula ID, with a cover index.
Request from factory: document index mapped to formula ID and batch, with revision numbers.

5. Challenge test quietly skipped

Symptom: microbial counts drift upward in stability samples or in early market complaints.
Root cause: fragrance or pH change altered preservative efficacy, and no one assessed it.
Prevention: require a documented go/no-go decision on re-challenge, with rationale.
Request from factory: challenge test report or a signed risk-based waiver.

6. Claims outrun the evidence

Symptom: retail listing or ad copy makes an efficacy or therapeutic claim the file cannot support.
Root cause: marketing copy written independently of the regulatory review.
Prevention: approve claims before artwork lock, in both Arabic and English.
Request from factory: claim substantiation summary mapped to the specific tests performed.

7. Notification update left until the last minute

Symptom: goods ready, file not.
Root cause: the notifier was engaged after production instead of at change classification.
Prevention: bring the local responsible entity into week one.
Request from factory: complete technical pack delivered early enough for the notifier to act.

FAQ

Does a fragrance supplier change require a new Saudi notification?

That is a decision for your local notifier, based on the nature and extent of the change. What is not optional is the underlying work: an updated ingredient risk review, allergen and IFRA documentation, a re-check of warnings, an assessment of whether a tolerance re-test is needed, and a decision on whether the safety file must be amended. Bring the notifier the technical pack and let them rule on the filing route.

Can we skip the challenge test if the preservative is unchanged?

Not automatically. A fragrance change can alter pH, nutrient availability, or preservative partitioning. The correct answer is a documented, risk-based assessment that concludes either “re-test required” or “no re-test required, with rationale.” A silent skip is the failure mode.

Our packaging is unchanged — do we still need to recheck it?

Yes, if the formula changed. Compatibility depends on the interaction between the fill and the pack, not on the pack alone. Viscosity shifts can change dropper performance, and solvent changes can affect gasket swelling or label adhesion.

Can we reuse the old Arabic label artwork?

Only after review. Ingredient order, allergen declarations, warnings, and any claim wording must reflect the new formula. Artwork should be approved by the importer in writing before printing, and the approved version should be tied to the formula ID.

Does the Gulf work as a single market for this?

No. Saudi Arabia and the UAE differ in regulatory pathway, import process, channel structure, and labeling expectations. Lock your first launch country, build the file for it, and adapt rather than assume.

Next step

If you are reformulating a serum that is already on the Saudi market, the fastest way to reduce risk is to start with the change classification and the document pack, not with the batch. Send us your target market, SKU and format, positioning, packaging direction, and timeline target, and we will come back with a scoped plan and a quote for the testing and documentation you actually need.

Request a Quote

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).